Search Results

Filter
  • 1-10 of  344 results for ""Anti-HIV Agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients.

Subjects: HIV-1*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Atazanavir Sulfate/Atazanavir Sulfate/Atazanavir Sulfate/*adverse effects

  • Source: HIV clinical trials [HIV Clin Trials] 2018 Aug; Vol. 19 (4), pp. 158-162. Date of Electronic Publication: 2018 Nov 13.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system.

  • Authors : Horberg MA; a Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States , Rockville , MD , USA.; Oakes AH

Subjects: Delivery of Health Care, Integrated* ; Product Surveillance, Postmarketing*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use

  • Source: HIV clinical trials [HIV Clin Trials] 2018 Oct; Vol. 19 (5), pp. 177-187. Date of Electronic Publication: 2018 Oct 27.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial.

Subjects: HIV-1* ; Pre-Exposure Prophylaxis*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use

  • Source: HIV clinical trials [HIV Clin Trials] 2018 Aug; Vol. 19 (4), pp. 129-138. Date of Electronic Publication: 2018 Nov 16.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.

  • Authors : Molas E; a Infectious Diseases Department, Hospital del Mar, Department of Medicine , Universitat Autònoma de Barcelona , Barcelona , Spain.; Luque S

Subjects: Drug Interactions*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*adverse effects ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacokinetics

  • Source: HIV clinical trials [HIV Clin Trials] 2018 Feb; Vol. 19 (1), pp. 1-7. Date of Electronic Publication: 2017 Nov 28.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals.

  • Authors : Jackson A; a St Stephen's Centre, Chelsea and Westminster Hospital , London , UK.; b Department of Clinical and Molecular Pharmacology , University of Liverpool , Liverpool , UK.

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacokinetics ; Darunavir/Darunavir/Darunavir/*pharmacokinetics ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: HIV clinical trials [HIV Clin Trials] 2018 Feb; Vol. 19 (1), pp. 31-37. Date of Electronic Publication: 2017 Nov 30.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials.

  • Authors : Mhlanga FG; a Department of Obstetrics and Gynaecology , College of Health Sciences, University of Zimbabwe , Harare , Zimbabwe.; b UZ-UCSF Women's Collaborative Research Programme , Harare , Zimbabwe.

Subjects: Registries*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacology

  • Source: HIV clinical trials [HIV Clin Trials] 2018 Feb; Vol. 19 (1), pp. 8-14. Date of Electronic Publication: 2017 Dec 21.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain.

Subjects: Costs and Cost Analysis*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/*methods

  • Source: HIV clinical trials [HIV Clin Trials] 2017 Nov-Dec; Vol. 18 (5-6), pp. 214-222.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Internet ISSN: 1945-5771

Record details

×
Academic Journal

Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women.

  • Authors : Brites C; a LAPI - Laboratório de Pesquisa em Infectologia , Comlexo Hospitalar Prof. Edgard Santos, Universidade Federal da Bahia , Salvador , Brazil.; Nóbrega I

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; Infectious Disease Transmission, Vertical/Infectious Disease Transmission, Vertical/Infectious Disease Transmission, Vertical/*prevention & control

  • Source: HIV clinical trials [HIV Clin Trials] 2018 Jun; Vol. 19 (3), pp. 94-100. Date of Electronic Publication: 2018 Apr 09.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial.

  • Authors : Post FA; a Kings College Hospital NHS Foundation Trust , Weston Education Centre (2.53) , London , UK.; Yazdanpanah Y

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/*methods ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: HIV clinical trials [HIV Clin Trials] 2017 May; Vol. 18 (3), pp. 135-140. Date of Electronic Publication: 2017 Mar 17.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/*methods ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: HIV clinical trials [HIV Clin Trials] 2017 May; Vol. 18 (3), pp. 118-125. Date of Electronic Publication: 2017 May 30.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  344 results for ""Anti-HIV Agents""